(b) On July 5, 2006, Gina Gutzeit relinquished her role as Interim Chief Financial Officer of Savient Pharmaceuticals, Inc. (the “Company”).
(c) On July 5, 2006, Brian J. Hayden was appointed Senior Vice President – Chief Financial Officer & Treasurer of the Company.
A copy of Mr. Hayden’s Employment Agreement and press release announcing his appointment are attached as Exhibits 10.1 and 99.1, respectively, to the Company’s Current Report on Form 8-K filed on July 11, 2006, which is incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits
(c) Exhibits
None.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| SAVIENT PHARMACEUTICALS, INC. | |
| Date: July 11, 2006 | By: /s/ Philip K. Yachmetz |
| Philip K. Yachmetz Executive Vice President & Chief Business Officer |
